HEADER ANTIVIRAL PROTEIN 01-APR-22 7ZFM TITLE ENGINEERED PROTEIN TARGETING THE ZIKA VIRAL ENVELOPE FUSION LOOP COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPIASE A,CYCLOPHILIN A,ROTAMASE A,ZVAP3; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: PPIA, ROT, ROTA, B3363, JW3326; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET14B KEYWDS ZIKV, NEUTRALIZATION, E PROTEIN, FUSION LOOP, ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.ATHAYDE,M.ARCHER,I.F.T.VIANA,W.C.S.ADAN,L.S.S.XAVIER,R.D.LINS REVDAT 2 31-JAN-24 7ZFM 1 JRNL REVDAT 1 17-AUG-22 7ZFM 0 JRNL AUTH I.F.T.VIANA,C.H.B.CRUZ,D.ATHAYDE,W.C.S.ADAN,L.S.S.XAVIER, JRNL AUTH 2 M.ARCHER,R.D.LINS JRNL TITL IN VITRO NEUTRALISATION OF ZIKA VIRUS BY AN ENGINEERED JRNL TITL 2 PROTEIN TARGETING THE VIRAL ENVELOPE FUSION LOOP JRNL REF SSRN 2022 JRNL REFN ESSN 1556-5068 JRNL DOI 10.2139/SSRN.4141045 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.V.AFONINE,R.W.GROSSE-KUNSTLEVE,N.ECHOLS,J.J.HEADD, REMARK 1 AUTH 2 N.W.MORIARTY,M.MUSTYAKIMOV,T.C.TERWILLIGER,A.URZHUMTSEV, REMARK 1 AUTH 3 P.H.ZWART,P.D.ADAMS REMARK 1 TITL TOWARDS AUTOMATED CRYSTALLOGRAPHIC STRUCTURE REFINEMENT WITH REMARK 1 TITL 2 PHENIX.REFINE. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 68 352 2012 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 22505256 REMARK 1 DOI 10.1107/S0907444912001308 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX. REMARK 1 REF ACTA CRYSTALLOGR D STRUCT V. 75 861 2019 REMARK 1 REF 2 BIOL REMARK 1 REFN ISSN 2059-7983 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.VONRHEIN,C.FLENSBURG,P.KELLER,A.SHARFF,O.SMART,W.PACIOREK, REMARK 1 AUTH 2 T.WOMACK,G.BRICOGNE REMARK 1 TITL DATA PROCESSING AND ANALYSIS WITH THE AUTOPROC TOOLBOX. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 67 293 2011 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 21460447 REMARK 1 DOI 10.1107/S0907444911007773 REMARK 1 REFERENCE 4 REMARK 1 AUTH W.KABSCH REMARK 1 TITL XDS. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 66 125 2010 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 20124692 REMARK 1 DOI 10.1107/S0907444909047337 REMARK 1 REFERENCE 5 REMARK 1 AUTH P.EVANS REMARK 1 TITL SCALING AND ASSESSMENT OF DATA QUALITY. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 62 72 2006 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 16369096 REMARK 1 DOI 10.1107/S0907444905036693 REMARK 1 REFERENCE 6 REMARK 1 AUTH P.R.EVANS,G.N.MURSHUDOV REMARK 1 TITL HOW GOOD ARE MY DATA AND WHAT IS THE RESOLUTION? REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 69 1204 2013 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 23793146 REMARK 1 DOI 10.1107/S0907444913000061 REMARK 1 REFERENCE 7 REMARK 1 AUTH M.D.WINN,C.C.BALLARD,K.D.COWTAN,E.J.DODSON,P.EMSLEY, REMARK 1 AUTH 2 P.R.EVANS,R.M.KEEGAN,E.B.KRISSINEL,A.G.LESLIE,A.MCCOY, REMARK 1 AUTH 3 S.J.MCNICHOLAS,G.N.MURSHUDOV,N.S.PANNU,E.A.POTTERTON, REMARK 1 AUTH 4 H.R.POWELL,R.J.READ,A.VAGIN,K.S.WILSON REMARK 1 TITL OVERVIEW OF THE CCP4 SUITE AND CURRENT DEVELOPMENTS. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 67 235 2011 REMARK 1 REFN ESSN 1399-0047 REMARK 1 PMID 21460441 REMARK 1 DOI 10.1107/S0907444910045749 REMARK 2 REMARK 2 RESOLUTION. 1.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.22 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 88.5 REMARK 3 NUMBER OF REFLECTIONS : 37153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1777 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.71 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 21.91 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2879 REMARK 3 BIN FREE R VALUE : 0.3234 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2520 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 135 REMARK 3 SOLVENT ATOMS : 291 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.39390 REMARK 3 B22 (A**2) : -0.39390 REMARK 3 B33 (A**2) : 0.78780 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.126 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.152 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.112 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5321 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 9504 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1610 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 898 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2797 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 352 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 15 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4468 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.79 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 21.1272 45.2463 49.0288 REMARK 3 T TENSOR REMARK 3 T11: -0.0038 T22: -0.0694 REMARK 3 T33: 0.0061 T12: 0.029 REMARK 3 T13: 0.0281 T23: 0.0013 REMARK 3 L TENSOR REMARK 3 L11: 0.6391 L22: 1.9148 REMARK 3 L33: 1.5408 L12: 0.1554 REMARK 3 L13: -0.4211 L23: -0.1999 REMARK 3 S TENSOR REMARK 3 S11: 0.0099 S12: 0.1671 S13: -0.0537 REMARK 3 S21: 0.1671 S22: 0.0273 S23: -0.0558 REMARK 3 S31: -0.0537 S32: -0.0558 S33: -0.0372 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 50.3808 50.3117 38.2431 REMARK 3 T TENSOR REMARK 3 T11: -0.1077 T22: 0.076 REMARK 3 T33: -0.0561 T12: -0.0584 REMARK 3 T13: -0.013 T23: 0.079 REMARK 3 L TENSOR REMARK 3 L11: 1.4909 L22: 2.0964 REMARK 3 L33: 1.8928 L12: 0.0693 REMARK 3 L13: -0.2986 L23: -1.1332 REMARK 3 S TENSOR REMARK 3 S11: 0.0926 S12: 0.0632 S13: -0.1025 REMARK 3 S21: 0.0632 S22: -0.3143 S23: 0.302 REMARK 3 S31: -0.1025 S32: 0.302 S33: 0.2217 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZFM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292120608. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97926 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC 1.0.5 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4, XDS BUILT REMARK 200 20200417 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37153 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.711 REMARK 200 RESOLUTION RANGE LOW (A) : 66.221 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 12.91 REMARK 200 R MERGE (I) : 0.04510 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.4500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 5.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 66.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 12.42 REMARK 200 R MERGE FOR SHELL (I) : 0.02360 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 85.39 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 1J2A REMARK 200 REMARK 200 REMARK: CLEAR OCTAHEDRON SHAPED CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M SUCCINIC ACID, 0.1 M HEPES PH REMARK 280 7.0 AND 1% W/V PEG 2000 MME, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.64100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.80900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.80900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.96150 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.80900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.80900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.32050 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.80900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.80900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 84.96150 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.80900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.80900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.32050 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.64100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1275 LIES ON A SPECIAL POSITION. REMARK 375 HOH B1213 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -20 REMARK 465 GLY A -19 REMARK 465 SER A -18 REMARK 465 SER A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 SER A -10 REMARK 465 SER A -9 REMARK 465 GLY A -8 REMARK 465 LEU A -7 REMARK 465 VAL A -6 REMARK 465 PRO A -5 REMARK 465 ARG A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 LYS A 2 REMARK 465 SER A 168 REMARK 465 GLY A 169 REMARK 465 CYS A 170 REMARK 465 MET B -20 REMARK 465 GLY B -19 REMARK 465 SER B -18 REMARK 465 SER B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 SER B -10 REMARK 465 SER B -9 REMARK 465 GLY B -8 REMARK 465 LEU B -7 REMARK 465 VAL B -6 REMARK 465 PRO B -5 REMARK 465 ARG B -4 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 ALA B 1 REMARK 465 LYS B 2 REMARK 465 SER B 168 REMARK 465 GLY B 169 REMARK 465 CYS B 170 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 97 37.67 -98.26 REMARK 500 THR A 100 -94.29 -124.99 REMARK 500 ASP A 145 -147.56 -95.28 REMARK 500 VAL A 146 139.14 -34.52 REMARK 500 SER A 151 -3.29 79.04 REMARK 500 SER A 151 -1.50 77.73 REMARK 500 TYR B 53 -69.17 -133.95 REMARK 500 ASP B 97 37.29 -98.21 REMARK 500 THR B 100 -93.11 -125.94 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ZFM A 1 163 UNP P0AFL3 PPIA_ECOLI 25 187 DBREF 7ZFM B 1 163 UNP P0AFL3 PPIA_ECOLI 25 187 SEQADV 7ZFM MET A -20 UNP P0AFL3 INITIATING METHIONINE SEQADV 7ZFM GLY A -19 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A -18 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A -17 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -16 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -15 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -14 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -13 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -12 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -11 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A -10 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A -9 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY A -8 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM LEU A -7 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM VAL A -6 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM PRO A -5 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM ARG A -4 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY A -3 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A -2 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS A -1 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM MET A 0 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A 22 UNP P0AFL3 LYS 46 ENGINEERED MUTATION SEQADV 7ZFM LEU A 33 UNP P0AFL3 VAL 57 ENGINEERED MUTATION SEQADV 7ZFM ASN A 38 UNP P0AFL3 SER 62 ENGINEERED MUTATION SEQADV 7ZFM SER A 48 UNP P0AFL3 ARG 72 ENGINEERED MUTATION SEQADV 7ZFM TYR A 53 UNP P0AFL3 PHE 77 ENGINEERED MUTATION SEQADV 7ZFM TYR A 60 UNP P0AFL3 PHE 84 ENGINEERED MUTATION SEQADV 7ZFM ASP A 63 UNP P0AFL3 GLN 87 ENGINEERED MUTATION SEQADV 7ZFM GLN A 68 UNP P0AFL3 LYS 92 ENGINEERED MUTATION SEQADV 7ZFM MET A 91 UNP P0AFL3 ALA 115 ENGINEERED MUTATION SEQADV 7ZFM GLU A 94 UNP P0AFL3 ALA 118 ENGINEERED MUTATION SEQADV 7ZFM TYR A 112 UNP P0AFL3 PHE 136 ENGINEERED MUTATION SEQADV 7ZFM ALA A 113 UNP P0AFL3 LEU 137 ENGINEERED MUTATION SEQADV 7ZFM THR A 118 UNP P0AFL3 ARG 142 ENGINEERED MUTATION SEQADV 7ZFM ARG A 119 UNP P0AFL3 ASP 143 ENGINEERED MUTATION SEQADV 7ZFM TYR A 120 UNP P0AFL3 PHE 144 ENGINEERED MUTATION SEQADV 7ZFM PHE A 122 UNP P0AFL3 TYR 146 ENGINEERED MUTATION SEQADV 7ZFM SER A 151 UNP P0AFL3 ASN 175 ENGINEERED MUTATION SEQADV 7ZFM THR A 163 UNP P0AFL3 LYS 187 ENGINEERED MUTATION SEQADV 7ZFM VAL A 164 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM LEU A 165 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM PRO A 166 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY A 167 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER A 168 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY A 169 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM CYS A 170 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM MET B -20 UNP P0AFL3 INITIATING METHIONINE SEQADV 7ZFM GLY B -19 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B -18 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B -17 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -16 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -15 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -14 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -13 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -12 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -11 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B -10 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B -9 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY B -8 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM LEU B -7 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM VAL B -6 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM PRO B -5 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM ARG B -4 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY B -3 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B -2 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM HIS B -1 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM MET B 0 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B 22 UNP P0AFL3 LYS 46 ENGINEERED MUTATION SEQADV 7ZFM LEU B 33 UNP P0AFL3 VAL 57 ENGINEERED MUTATION SEQADV 7ZFM ASN B 38 UNP P0AFL3 SER 62 ENGINEERED MUTATION SEQADV 7ZFM SER B 48 UNP P0AFL3 ARG 72 ENGINEERED MUTATION SEQADV 7ZFM TYR B 53 UNP P0AFL3 PHE 77 ENGINEERED MUTATION SEQADV 7ZFM TYR B 60 UNP P0AFL3 PHE 84 ENGINEERED MUTATION SEQADV 7ZFM ASP B 63 UNP P0AFL3 GLN 87 ENGINEERED MUTATION SEQADV 7ZFM GLN B 68 UNP P0AFL3 LYS 92 ENGINEERED MUTATION SEQADV 7ZFM MET B 91 UNP P0AFL3 ALA 115 ENGINEERED MUTATION SEQADV 7ZFM GLU B 94 UNP P0AFL3 ALA 118 ENGINEERED MUTATION SEQADV 7ZFM TYR B 112 UNP P0AFL3 PHE 136 ENGINEERED MUTATION SEQADV 7ZFM ALA B 113 UNP P0AFL3 LEU 137 ENGINEERED MUTATION SEQADV 7ZFM THR B 118 UNP P0AFL3 ARG 142 ENGINEERED MUTATION SEQADV 7ZFM ARG B 119 UNP P0AFL3 ASP 143 ENGINEERED MUTATION SEQADV 7ZFM TYR B 120 UNP P0AFL3 PHE 144 ENGINEERED MUTATION SEQADV 7ZFM PHE B 122 UNP P0AFL3 TYR 146 ENGINEERED MUTATION SEQADV 7ZFM SER B 151 UNP P0AFL3 ASN 175 ENGINEERED MUTATION SEQADV 7ZFM THR B 163 UNP P0AFL3 LYS 187 ENGINEERED MUTATION SEQADV 7ZFM VAL B 164 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM LEU B 165 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM PRO B 166 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY B 167 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM SER B 168 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM GLY B 169 UNP P0AFL3 EXPRESSION TAG SEQADV 7ZFM CYS B 170 UNP P0AFL3 EXPRESSION TAG SEQRES 1 A 191 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 191 LEU VAL PRO ARG GLY SER HIS MET ALA LYS GLY ASP PRO SEQRES 3 A 191 HIS VAL LEU LEU THR THR SER ALA GLY ASN ILE GLU LEU SEQRES 4 A 191 GLU LEU ASP SER GLN LYS ALA PRO VAL SER VAL GLN ASN SEQRES 5 A 191 PHE LEU ASP TYR VAL ASN ASN GLY PHE TYR ASN ASN THR SEQRES 6 A 191 THR PHE HIS SER VAL ILE PRO GLY TYR MET ILE GLN GLY SEQRES 7 A 191 GLY GLY TYR THR GLU ASP MET GLN GLN LYS GLN PRO ASN SEQRES 8 A 191 PRO PRO ILE LYS ASN GLU ALA ASP ASN GLY LEU ARG ASN SEQRES 9 A 191 THR ARG GLY THR ILE ALA MET MET ARG THR GLU ASP LYS SEQRES 10 A 191 ASP SER ALA THR SER GLN PHE PHE ILE ASN VAL ALA ASP SEQRES 11 A 191 ASN ALA TYR ALA ASP HIS GLY GLN THR ARG TYR GLY PHE SEQRES 12 A 191 ALA VAL PHE GLY LYS VAL VAL LYS GLY MET ASP VAL ALA SEQRES 13 A 191 ASP LYS ILE SER GLN VAL PRO THR HIS ASP VAL GLY PRO SEQRES 14 A 191 TYR GLN SER VAL PRO SER LYS PRO VAL VAL ILE LEU SER SEQRES 15 A 191 ALA THR VAL LEU PRO GLY SER GLY CYS SEQRES 1 B 191 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 191 LEU VAL PRO ARG GLY SER HIS MET ALA LYS GLY ASP PRO SEQRES 3 B 191 HIS VAL LEU LEU THR THR SER ALA GLY ASN ILE GLU LEU SEQRES 4 B 191 GLU LEU ASP SER GLN LYS ALA PRO VAL SER VAL GLN ASN SEQRES 5 B 191 PHE LEU ASP TYR VAL ASN ASN GLY PHE TYR ASN ASN THR SEQRES 6 B 191 THR PHE HIS SER VAL ILE PRO GLY TYR MET ILE GLN GLY SEQRES 7 B 191 GLY GLY TYR THR GLU ASP MET GLN GLN LYS GLN PRO ASN SEQRES 8 B 191 PRO PRO ILE LYS ASN GLU ALA ASP ASN GLY LEU ARG ASN SEQRES 9 B 191 THR ARG GLY THR ILE ALA MET MET ARG THR GLU ASP LYS SEQRES 10 B 191 ASP SER ALA THR SER GLN PHE PHE ILE ASN VAL ALA ASP SEQRES 11 B 191 ASN ALA TYR ALA ASP HIS GLY GLN THR ARG TYR GLY PHE SEQRES 12 B 191 ALA VAL PHE GLY LYS VAL VAL LYS GLY MET ASP VAL ALA SEQRES 13 B 191 ASP LYS ILE SER GLN VAL PRO THR HIS ASP VAL GLY PRO SEQRES 14 B 191 TYR GLN SER VAL PRO SER LYS PRO VAL VAL ILE LEU SER SEQRES 15 B 191 ALA THR VAL LEU PRO GLY SER GLY CYS HET EDO A1001 4 HET EDO A1002 4 HET EDO A1003 4 HET EDO A1004 4 HET EDO A1005 4 HET EDO A1006 4 HET EDO A1007 4 HET EDO A1008 4 HET P6G A1009 19 HET PGE A1010 10 HET ACY A1011 4 HET ACY A1012 4 HET ACY A1013 4 HET SIN A1014 8 HET EDO A1015 4 HET EDO B1001 4 HET EDO B1002 4 HET EDO B1003 4 HET EDO B1004 4 HET EDO B1005 4 HET EDO B1006 4 HET EDO B1007 4 HET PGE B1008 10 HET SIN B1009 8 HET EDO B1010 4 HETNAM EDO 1,2-ETHANEDIOL HETNAM P6G HEXAETHYLENE GLYCOL HETNAM PGE TRIETHYLENE GLYCOL HETNAM ACY ACETIC ACID HETNAM SIN SUCCINIC ACID HETSYN EDO ETHYLENE GLYCOL HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 3 EDO 17(C2 H6 O2) FORMUL 11 P6G C12 H26 O7 FORMUL 12 PGE 2(C6 H14 O4) FORMUL 13 ACY 3(C2 H4 O2) FORMUL 16 SIN 2(C4 H6 O4) FORMUL 28 HOH *291(H2 O) HELIX 1 AA1 ALA A 25 ASN A 38 1 14 HELIX 2 AA2 GLU A 76 GLY A 80 5 5 HELIX 3 AA3 ASN A 110 ASP A 114 5 5 HELIX 4 AA4 GLY A 131 GLN A 140 1 10 HELIX 5 AA5 ALA B 25 ASN B 38 1 14 HELIX 6 AA6 GLU B 76 GLY B 80 5 5 HELIX 7 AA7 ASN B 110 ASP B 114 5 5 HELIX 8 AA8 GLY B 131 GLN B 140 1 10 HELIX 9 AA9 VAL B 146 GLN B 150 5 5 SHEET 1 AA1 9 THR A 44 THR A 45 0 SHEET 2 AA1 9 VAL A 158 VAL A 164 -1 O ILE A 159 N THR A 44 SHEET 3 AA1 9 HIS A 6 THR A 11 -1 N THR A 10 O SER A 161 SHEET 4 AA1 9 GLY A 14 LEU A 20 -1 O ILE A 16 N LEU A 9 SHEET 5 AA1 9 VAL A 124 LYS A 130 -1 O VAL A 129 N GLU A 17 SHEET 6 AA1 9 THR A 87 MET A 90 -1 N ILE A 88 O PHE A 125 SHEET 7 AA1 9 PHE A 103 ASN A 106 -1 O PHE A 104 N ALA A 89 SHEET 8 AA1 9 MET A 54 GLY A 57 -1 N ILE A 55 O ILE A 105 SHEET 9 AA1 9 SER A 48 ILE A 50 -1 N ILE A 50 O MET A 54 SHEET 1 AA2 9 HIS B 6 THR B 11 0 SHEET 2 AA2 9 GLY B 14 LEU B 20 -1 O ILE B 16 N LEU B 9 SHEET 3 AA2 9 VAL B 124 LYS B 130 -1 O VAL B 129 N GLU B 17 SHEET 4 AA2 9 THR B 87 MET B 90 -1 N ILE B 88 O PHE B 125 SHEET 5 AA2 9 PHE B 103 ASN B 106 -1 O PHE B 104 N ALA B 89 SHEET 6 AA2 9 MET B 54 THR B 61 -1 N ILE B 55 O ILE B 105 SHEET 7 AA2 9 THR B 44 ILE B 50 -1 N ILE B 50 O MET B 54 SHEET 8 AA2 9 VAL B 158 VAL B 164 -1 O ILE B 159 N THR B 44 SHEET 9 AA2 9 HIS B 6 THR B 11 -1 N THR B 10 O SER B 161 CRYST1 81.618 81.618 113.282 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012252 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012252 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008828 0.00000